Tevogen Bio (TVGN) to Evaluate Potential One-Time Special Cash Dividend

Tevogen (Nasdaq: TVGN) today announced that its Board of Directors has expressed its intention to evaluate the potential declaration of a one-time special cash dividend to shareholders, contingent upon the achievement of specified financial milestones to be determined at a future date, which could include revenue and earnings targets.

Any consideration of a special dividend would be subject to the Company’s future financial performance, capital requirements, compliance with applicable solvency laws, including under the Delaware General Corporation Law, and final approval by the Board of Directors after a determination that a dividend would be the best use of Company capital at the time. No assurance can be given that a dividend will be declared, nor as to the timing or amount of any such dividend.

Further updates will be provided as appropriate and in accordance with applicable disclosure requirements.

You May Also Be Interested In

• Invesco Mortgage Capital declares $0.12 monthly dividend for June 2026
• XORTX to voluntarily delist from TSX Venture Exchange
• Nvidia pitches Vera CPU to Chinese clients with August delivery target